The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies. 

The deal will create a Therapy Command Center to support the study and use of theranostics across Massachusetts General Hospital and its affiliated centers in bordering states. 

The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers. 

New data highlight the significance of tau-positive imaging in the progression of Alzheimer’s disease. 

New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments. 

Experts believe their findings could be significant for treating both pain and mental health disorders. 

Researchers are hopeful that their technique could improve the diagnosis of conditions associated with neural inflammation. 

Researchers have developed a new radiotracer that targets one of the virus’ spike proteins, allowing them to track it longitudinally.